Urinary Vitamin C Loss in Diabetic Subjects
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00071526|
Recruitment Status : Recruiting
First Posted : October 28, 2003
Last Update Posted : January 10, 2022
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||5000 participants|
|Official Title:||Urinary Vitamin C Loss in Subjects With and Without Diabetes|
|Actual Study Start Date :||April 11, 2006|
Diabetes Type I
Subjects with Type I diabetes mellitus
Diabetes Type II
Subjects with Type II diabetes mellitus
- Plasma, neutrophil and RBC Vitamin C concentrates [ Time Frame: end of study ]Measurements of plasma, neutrophil and red blood cell vitamin c concentrations in diabetic subjects as compared to healthy controls.
- Urinary vitamin C concentration [ Time Frame: end of study ]Measurements of urinary vitamin c concentrations in diabetic subjects as compared to healthy controls.
- Determine the renal threshold and relative bioavailability for vitamin C [ Time Frame: end of study ]Calculate renal threshold of vitamin C in diabetic subjects as compared to healthy controls.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00071526
|Contact: Irene T Rozga, R.N.||(301) email@example.com|
|Contact: Ifechukwude C Ebenuwa, M.D.||(301) firstname.lastname@example.org|
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Recruiting|
|Bethesda, Maryland, United States, 20892|
|Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 email@example.com|
|Principal Investigator:||Ifechukwude C Ebenuwa, M.D.||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|